Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The denatured collagen triple-helix structural motif refers to the unfolded or degraded state of collagen proteins, which are the primary structural components of the extracellular matrix (ECM) (NIH.gov; 3helix.com). In healthy tissues, collagen exists as a stable, triple-helical structure that is highly resistant to most proteolytic enzymes (YouTube.com; NIH.gov). However, during pathological conditions such as cancer, inflammation, and mechanical injury, the triple helix is cleaved by matrix metalloproteinases (MMPs) or physically disrupted, causing the strands to spontaneously unfold at physiological temperatures (3helix.com; NIH.gov). This denaturation exposes cryptic binding sites and individual alpha chains that are not accessible in intact collagen, making the motif a highly specific biomarker for active tissue damage and remodeling (Ilexlife.com; NIH.gov). Therapeutic and diagnostic strategies, most notably Collagen Hybridizing Peptides (CHPs), target this motif by re-hybridizing with the exposed strands to form a new, stable triple helix (NIH.gov; Wikipedia.org). This unique mechanism enables the targeted delivery of imaging agents and drugs to diseased environments, such as the invasive front of tumors or the degraded cartilage in arthritic joints (NIH.gov). Experimental applications include the localization of anti-TNF alpha antibodies to arthritic joints and the imaging of tumor-associated ECM remodeling (NIH.gov). Because the collagen sequence is highly conserved, these targeting agents can be applied across various species and collagen types (3helix.com).
Triple-helical hybridization with denatured collagen strands to deliver therapeutic or imaging payloads
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Denatured collagen triple-helix structural motif (dCol).